1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ACADIA PHARMACEUTICALS INC
Acadia Pharmaceuticals Inc XNAS: ACAD

Acadia Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuros...

Read More
25.34 0.08 (0.32%)
Near 52W High of $26.65
516.6K
XNAS Volume

XNAS 08 Sep, 2025 12:49 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Acadia Pharmaceuticals Inc is on 18 Sep 2025 for the purpose of TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit See details
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Mid Valuation
49.3 / 100
Momentum Score
Technically Moderately Bullish
63.1 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
30
1Yr Price target upside is 18%
19 analysts

21

S

2

W

0

O

2

T

SWOT Analysis

Acadia Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..